97 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
22 Apr 24
Report of Foreign Private Issuer
8:02am
and confirmation by the independent Data and Safety Monitoring Board. In addition to evaluating safety, the blinded randomized stage is statistically-powered
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
8:00am
following the completion of the safety run-in stage and confirmation by the independent Data and Safety Monitoring Board. In addition to evaluating safety
6-K
EX-99.1
8s8wx4u2vuc d2pz
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
6-K
EX-99.2
dws5weht
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
09oxf83 tiutrfc8x
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
zbl4jd581f0zx
17 Jan 24
Report of Foreign Private Issuer
8:02am
6-K
EX-99.2
1o4hiq
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
ii8syrt9p1dotbg
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
nyuphtvr6ru
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
hc8xd2fb
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
rf2zw80pzn guw2
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.2
igvv1aslut7euj7x2epr
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
9tb8heke
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
mbncw pg89
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
retxo3k91 flz3155o
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm